ANIP's logo.
Ticker Symbol: ANIP

ANI Pharmaceuticals Inc

$44.63 - 09-10-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001023024

Company Profile

ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 210 W Main St
CEO: Patrick Walsh
Tags:
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $57.44
Change: $0.13 ( 0.23%)
Days Range: $57.20 - $58.82
Beta: 0.94
52wk. High: $65.89
52wk. Low: $32.15
Ytd. Change 43.01%
50 Day Moving Average: $59.83
200 Day Moving Average: $51.87
Shares Outstanding: 20280798

Valuation

Market Cap: 116.5B
PE Ratio: -128.53
EPS (TTM): -0.4469

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A